Get in touch today 206.598.4100 or

Schedule an Appointment

Christine Fang, M.D.

Assistant Professor

Locations of Practice

SCCA Proton Therapy

1570 N 115th Street
Seattle, WA 98133

Locate on Google Maps


Dr. Fang is a radiation oncologist who specializes in treating breast and gynecologic cancers. She has special expertise in proton beam radiation therapy.

Patient Care Philosophy

The most important aspect to my work is delivering the best care possible to my patients. This includes evidence-based, personalized medical management, compassion, empathy, patience, and delivery of hope. I believe in treating the person, not the disease. I place a strong emphasis on clear communication with my patients so that there is a clear understanding of the disease process, prognosis, treatment options, and what is to be expected during treatment.

Education and Training

College: University of California at Berkeley, Berkeley, CA, 1999

Medical School: University of Utah School of Medicine, Salt Lake City, UT, 2005

Residency: University of Washington Medical Center, Seattle, WA, 2010

Fellowship: Proton Therapy, MD Anderson Cancer Center, Houston, TX, 2011

Published Works

Fang LC, Merrick GS, Butler WM, Galbreath RW, Murray BC, Reed JL, Adamovich E, Wallner KE. High-risk prostate cancer with Gleason score 8-10 and PSA level < 15ng/mL treated with permanent interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):992-6.

Fang LC, Merrick GS, Wallner KE. Androgen deprivation therapy: a survival benefit or detriment in men with high-risk prostate cancer? Oncology (Williston Park). 2010 Aug;24(9):790-6, 798. Review.

Fang LC, Dattoli M, Taira A, True L, Sorace R, Wallner K. Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy. Urology. 2008 Jan;71(1):146-50.

Fang LC, Komaki R, Allen P, Guerrero T, Mohan R, Cox JD. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):108-16.

Board Certification

American Board of Radiology, Radiation Oncology, 2011